As part of the SIU ‘From Idea to Start-up’ event series, SIULondon hosted speakers to share their expertise on the topic of exploring the therapeutic potential of genetic engineering. Read on to learn about innovative companies Shift Bioscience, Touchlight Genetics and more…
Could there be some truth in Hippocrates’ belief that all disease begins in the gut? Recent research is showing us that there is an evident link between gut microbiota and microglial cells in the central nervous system. Read on here to find out more about this association and its importance to neurological function.
Will biotherapeutics become the new generation of drugs for treating Alzheimer’s disease? And how is this disease linked to inflammation in the brain? Read on here for more….
Is there a link between depression and inflammation in the brain? And what could this discovery mean for treating depression? Read on for more insights on the connection between the immune system and mental health.
The promising developments in immunotherapy in recent years catch the attention of not only patients and researchers but also investors. In this article we bring you the latest financial trends in immunotherapy investments.
Antibiotic resistance is something we hear of a lot these days. What does it actually mean? What causes it? What can we do to stop it? Are we about to enter a stage where we will be helpless against infections once again? In this article SIU brings you all the latest you need to know.
What do stem cells mean for life? Can they be used to create functional tissues and organs in the lab? How far are we from using them to mimic life? In this SIU article we discuss the latest in the field of stem cell research and bring you the answers to these questions.
Cancer is a disease that affects a substantial portion of the world population. Cancer immunotherapy is one of the latest methods to target the disease and it has gained a lot of momentum lately because of its potential as an effective therapy. In this article we describe what cancer immunotherapy means, the latest developments in the field and what we should expect from it in the near future.
Dementia is one of the biggest issues affecting the elderly. With our life expectancy being greater than ever and its expected further increase in the near future, the different neurodegenerative diseases that are all grouped under the name 'dementia' are important focus areas of therapeutic research. Alzheimer's is the main disease that leads to dementia and in this article we look at the current therapies and the latest innovative approaches to treat it.
The first Oxford session of the SIU360 educational series took place on October 18th, at the Saïd Business School, University of Oxford. Our speaker was Prof. Chas Bountra. The talk drew a large group of attendees, who were inspired by Prof. Bountra's engaging talk on open sourcing in translational research.
In a controversial paper published in the journal Protein & Cell earlier this year, Chinese scientists at Sun Yat-sen University reported the world’s first genomic editing of human embryos